A letter to the editor by The Philadelphia Inquirer’s James Neff raises concerns about conflicts of interest in a recent Guest Editorial published in The Cancer Letter. The authors and The Cancer Letter editor respond.
Richard Edelson began his career at NCI, where he was training to become a cancer immunologist.
This week came word of the passing of Franklyn Prendergast, professor emeritus of the Mayo College of Medicine and Science and director emeritus of the Mayo Clinic Comprehensive Cancer Center.
On Oct. 12, 2023, the world lost a brilliant mind, a dedicated physician and an extraordinary individual.
Franklyn Prendergast, emeritus professor of biochemistry, molecular biology, and pharmacology at Mayo Clinic College of Medicine and Science, was the first Black director of an NCI-designated cancer center.
When Ashani Weeraratna began her career as a trainee at Johns Hopkins in the 1990s, she was part of a team that conducted research in a grocery store-turned-laboratory.
OK, name a movie doctor—fast!Chances are, you are thinking of Robin Williams as Patch Adams in the eponymous flick or of Harrison Ford as Dr. Richard Kimble in “The Fugitive.”
NCI’s Surveillance, Epidemiology, and End Results Program in the Division of Cancer Control and Population Sciences at NCI is marking 50 years of cancer surveillance.
Mary Lasker was surprised when, in 1964, President Lyndon B. Johnson called her at home and asked whether she would accept the job of U.S. ambassador to Finland.
Letter to the editor by The Philadelphia Inquirer’s James NeffWe see far too many patients with glioblastoma (GBM), an aggressive and almost always fatal malignant brain tumor.
